Amylin, JDRF Team to Test Symlin/Insulin Combo for Type 1

Symlin and Insulin for Type 1's

| Jun 3, 2011

Amylin Pharmaceuticals has announced that it will collaborate with the Juvenile Diabetes Research Foundation to test a combination of Symlin and insulin in injectible form as a type 1 therapy.

Currently, people with type 1 diabetes who take Symlin and insulin inject them separately. The test will determine if taking the two together increases blood sugar control by reducing the number of separate daily injections, making it easier for type 1s to manage the disease.

Symlin (pramlintide acetate) is an artificial analog of amylin, which is a hormone the pancreas secretes into the bloodstream along with insulin after a meal. In people with diabetes, amylin may be deficient or non-existent.

Symlin works by promoting a sense of satiety, slowing gastric emptying-which helps with the absorption of glucose-and inhibiting glucagon secretion.  

The Amylin Pharmaceuticals-JDRF collaboration is the second one that the two partners have entered over the past year. In November, they announced that they would test whether metreleptin, a leptin mimic, can improve blood sugar control to the point of lowering the daily insulin dose required by patients with diabetes.

Click Here To View Or Post Comments

Categories: , Amylin Pharmaceuticals, Blood Glucose, Blood Sugar, Diabetes, Diabetes, Glucagon, Injection, JDRF, Symlin, Type 1 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.